DalsnaFinance › IPOs › Revolution Medicines › IPO
Revolution Medicines, Inc. completed its initial public offering on NASDAQ on February 13, 2020, pricing at $17.00 a share.
| Ticker | RVMD |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 13, 2020 |
| Offering price | $17.00 |
| Shares offered | 14,000,000 |
| Total raised | $238M |
Revolution Medicines, Inc. sold 14,000,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $238 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $238 million total recorded for the deal.
Revolution Medicines, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Revolution Medicines, Inc.. This page is general information, not investment advice.